InSysBio to participate in Quantitative Systems Pharmacology for Immuno-Oncology

events
Conference
April 4, 2022

April 4, 2022

InSysBio announces its participation in Quantitative Systems Pharmacology for Immuno-Oncology, a joint meeting of the EMBL's European Bioinformatics Institute (EMBL-EBI) & the UK QSP Network which is to be held 25th & 26th April 2022 in person at the EMBL-EBI Main Building, Wellcome Genome Campus, Hinxton, Cambridgeshire, UK, and online via Zoom. 

Oleg Demin Jr, InSysBio Scientific & Marketing Director, Oncology & Immuno-Oncology, will give a talk in frames of Theme 1: Combination Therapy.

Monday, April 25, 11:20-11:45

  • "Specific aspects of the implementation of different combination therapies in the QSP model"

About InSysBio

InSysBio is a Quantitative Systems Pharmacology (QSP) company located in Moscow, Russia (INSYSBIO LLC) and Edinburgh, UK (INSYSBIO UK LIMITED). InSysBio was founded in 2004 and has an extensive track record of helping pharmaceutical companies to make right decisions on the critical stages of drug research and development by application of QSP modeling. InSysBio’s innovative QSP approach has already become a part of the drug development process implemented by our strategic partners: there are more than 100 completed projects in collaboration with leaders of pharmaceutical industry. For more information about InSysBio, its solutions and services, visit www.insysbio.com.

May 2022
MoTuWeThFrSaSu
      
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
1. 24 May 2022 13:04 InSysBio to establish a new legal entity in Cyprus InSysBio announces the creation of a new legal entity INSYSBIO CY Ltd. InSysBio continues the development of its QSP services and QSP tools infrastructure and contributing its experience to global research. Oleg Demin, CEO of InSysBio, comments on the significance and goals of this step.
25
26
27
28
29
30
31
     
Upcoming Events
Tags
Latest News
11.07
InSysBio team to publish the new article in Journal of Pharmacokinetics and Pharmacodynamics
24.05
InSysBio to establish a new legal entity in Cyprus
25.04
InSysBio's ASCPT 2022 Micro-Theater Session on YouTube
20.01
InSysBio to release Immune Response Template v. 3.6.0
23.12
InSysBio to update CYTOCON DB and CYTOCON DB Open